Inhaled hormone therapy for asthma generally does not trigger obesity. Asthma patients often need to take inhaled hormone therapy, generally the use of glucocorticoid drugs such as budesonide, but in the use of only inhaled trace amounts of hormones, belonging to the local use of medication, mainly to reduce the local inflammatory response, alleviate the symptoms of asthma, the use of medication is not large, and generally will not lead to obesity. And in the acute attack of asthma, patients may also be systemic application of hormone drugs, is also a short-term application, most will not lead to obesity, a small number of patients will be temporarily obese, but after stopping the drug weight will gradually return to normal. Asthma patients must actively cooperate with the doctor to take treatment, do not arbitrarily stop reducing medication, to avoid causing repeated asthma attacks.